Stifel Reiterates Buy Rating on CONMED (CNMD)

February 4, 2025 10:03 AM EST Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $72.00 price target on CONMED (NYSE: CNMD).He said, "This note kicks ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login